Skip Navigation

European Journal of Echocardiography 2005 6(6):393-395; doi:10.1016/j.euje.2005.09.007
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Eur J Echocardiogr
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schwerzmann, M.
Right arrow Articles by Salehian, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwerzmann, M.
Right arrow Articles by Salehian, O.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, The European Society of Cardiology

Hazards of percutaneous PFO closure

Markus Schwerzmanna,* and Omid Salehianb

aAdult Congenital Heart Disease Program, Swiss Cardiovascular Center Bern, University Hospital Inselspital, 3010 Bern, Switzerland
bAdult Congenital Cardiology Clinic, McMaster University Medical Centre, Hamilton, ON, Canada

Received 21 September 2005; .

markus.schwerzmann@insel.ch

* Corresponding author. Tel.: +41 31 632 96 54; fax: +41 31 432 42 99.

The first 10% of the full text of this article appears below.

Please see the article by Christen et al. (doi: 10.1016/j.euje.2005.08.002) to which this editorial pertains.

In 2004, an estimated 2000–3000 patients underwent percutaneous closure of a patent foramen ovale (PFO). Given the range of potential indications (such as prevention of cryptogenic stroke, decompression illness in divers, platypnea–orthodeoxia syndrome, and migraine headaches) and the perception of PFO closure being an easy and safe procedure,1 the number of patients with percutaneously implanted PFO closure devices will continue to grow.

The first attempt to percutaneously close an interatrial defect was undertaken in 1974 and reported by King and colleagues in 1976.2 In the following years, several different devices were developed and re-modified to facilitate this . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Eur J Echocardiogr:

Late cardiac tamponade after percutaneous closure of a patent foramen ovale
Thomas Christen, François Mach, Dominique Didier, Afksendyios Kalangos, Vitali Verin, and Pedro T. Trindade
Eur J Echocardiogr 2005 6: 465-469. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 CirculationHome page
S. R. Messe and S. E. Kasner
Patent Foramen Ovale in Cryptogenic Stroke: Not to Close
Circulation, November 4, 2008; 118(19): 1999 - 2004.
[Full Text] [PDF]